Press Releases

Quarterly dividend increased by 6.45% to $0.33 from $0.31 per share. As of 2026-08-31, NAV Yield was 6.1%,

Quarterly dividend increased by 9.52% to $0.23 from $0.21 per share. As of 2026-08-31, NAV Yield was 5.4%,

The Fund is pleased to announce the closing of a private notes offering totaling $150.0 million in aggregate

Monthly dividend decreased by 0.27% to $0.073 from $0.0732 per share. As of 2026-08-31, NAV Yield was 7.9%,

Monthly dividend decreased by 1.43% to $0.069 from $0.07 per share. As of 2026-08-31, NAV Yield was 7.1%,

Quarterly dividend increased by 0.72% to $0.1546 from $0.1535 per share. As of 2026-08-31, NAV Yield was 5.1%,

Monthly dividend increased by 4.41% to $0.071 from $0.068 per share. As of 2026-08-31, NAV Yield was 6.8%,

The Fund today announced the commencement of a tender offer (“Tender Offer”) beginning September 1, 2026, and expiring

David A. Barnett has been appointed General Counsel and Chief Compliance Officer and Samantha X. Jin, Treasurer, has

Quarterly dividend decreased by 1.01% to $0.294 from $0.297 per share. As of 2026-08-31, NAV Yield was 8.2%,

Monthly dividend increased by 3.13% to $0.033 from $0.032 per share. As of 2026-08-31, NAV Yield was 6.8%,

Monthly dividend decreased by 0.14% to $0.0695 from $0.0696 per share. As of 2026-08-31, NAV Yield was 8.4%,

Effective as of Aug. 31, 2026, NHS's leverage comprises $50 million of Series D MRPS and borrowings under

Distribution amount: $0.18. Ex-div date 2026-09-10, Record date 2026-09-10, Payable date 2026-09-16.

The Board of Trustees of five Nuveen closed-end funds have approved changes to each Fund’s name. There will

The Company announced that PennantPark Senior Secured Loan Fund I LLC (“PSSL”), through PSSL’s wholly-owned and consolidated subsidiary,

The Board of Trustees of five Nuveen closed-end funds have approved changes to each Fund’s name. There will

The Board of Trustees of five Nuveen closed-end funds have approved changes to each Fund’s name. There will

The Board of Trustees of five Nuveen closed-end funds have approved changes to each Fund’s name. There will

The Board of Trustees of five Nuveen closed-end funds have approved changes to each Fund’s name. There will

As previously announced, the Board of Directors of Advanced Flower Capital Inc. (the “Company”) has authorized a program

Distribution amount: $0.06. Ex-div date 2026-12-15, Record date 2026-12-15, Payable date 2026-12-31.

The Boards of Trustees of six of Calamos Investments' closed-end funds (the Funds) today announced the issuance of

The Boards of Trustees of six of Calamos Investments' closed-end funds (the Funds) today announced the issuance of

The Boards of Trustees of six of Calamos Investments' closed-end funds (the Funds) today announced the issuance of

The Boards of Trustees of six of Calamos Investments' closed-end funds (the Funds) today announced the issuance of

The Fund today announced that its Board of Trustees (the “Board”) has approved the terms of the issuance

The Boards of Trustees of six of Calamos Investments' closed-end funds (the Funds) today announced the issuance of

The Boards of Trustees of six of Calamos Investments' closed-end funds (the Funds) today announced the issuance of

The Fund announced that its Board of Trustees approved a 1-for-3 reverse stock split of its common shares.

The Company will also host a conference call and webcast at 10:00am Eastern Time / 3:00pm UK time

The Fund today announced the successful completion of its over-subscribed transferable rights offer (the “Offer”) which expired on

The company announced 2026-06-30 financial results. Net investment income increased by 41.44% to $0.15 per share from $0.11

The Boards of Trustees of Saba Capital Income & Opportunities Fund (NYSE: BRW) and Saba Capital Income &

The Boards of Trustees of Saba Capital Income & Opportunities Fund (NYSE: BRW) and Saba Capital Income &

The Company will host a conference call on Friday, August 21, 2026 at 9:00 a.m. Eastern Time.

Monthly dividend decreased by 0.18% to $0.0726 from $0.07273 per share. As of 2026-08-17, NAV Yield was 8.9%,

Monthly dividend increased by 0.11% to $0.08794 from $0.08784 per share. As of 2026-08-17, NAV Yield was 8.4%,

Quarterly dividend increased by 4.29% to $0.14821 from $0.14211 per share. As of 2026-08-17, NAV Yield was 7.8%,

The Fund announced that the Fund's Board of Trustees (the "Board") has approved a 1-for-10 reverse share split

The Company announced that it has priced an underwritten public offering of $85,000,000 in aggregate principal amount of

Monthly dividend decreased by 0.3% to $0.0531 from $0.05326 per share. As of 2026-08-17, NAV Yield was 9.0%,